Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

207
Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
207
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

347
The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
347
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

785
Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
785
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

782
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
782
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT01:25

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

381
Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
381
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

531
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
531

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Comparative prognostic value of GNRI, PNI, and CONUT scores for long-term mortality in patients undergoing transcatheter aortic valve replacement.

BMC cardiovascular disorders·2026
Same author

The Monday Effect: Weekly and Circadian Patterns in Acute Cardiovascular Emergencies Monday Effect in Cardiovascular Emergencies.

Medicina (Kaunas, Lithuania)·2026
Same author

Impact of CHA₂DS₂-VA score on COVID-19 disease-related outcomes.

BMC cardiovascular disorders·2025
Same author

Electrical Risk Score as a Predictor of Coronary Artery Disease.

Journal of clinical medicine·2025
Same author

Efficacy and Safety of TriClip Procedure in Patients with Severe Tricuspid Regurgitation and Large Coaptation Gap.

Cardiovascular drugs and therapy·2025
Same author

Prognostic value of hemoglobin, albumin, lymphocyte, platelet (HALP) scores in patients with non-valvular atrial fibrillation: insights from the AFTER-2 study.

BMC cardiovascular disorders·2025

Related Experiment Video

Updated: Jan 13, 2026

Author Spotlight: Integrated Multi-Omics Analysis for Unveiling Multicellular Immune Signatures in Clinical Heart Attack Cohorts
08:51

Author Spotlight: Integrated Multi-Omics Analysis for Unveiling Multicellular Immune Signatures in Clinical Heart Attack Cohorts

Published on: September 20, 2024

2.0K

Beyond the GRACE Score: A Multi-Biomarker Model for Improved Risk Stratification in Acute Coronary Syndromes.

Gamze Yeter Arslan1, Erkan Baysal2

  • 1Department of Cardiology, Kepez State Hospital, 07320 Antalya, Türkiye.

Diagnostics (Basel, Switzerland)
|January 10, 2026
PubMed
Summary

Integrating inflammation, liver, and kidney function biomarkers with the GRACE score improves early mortality prediction in acute coronary syndromes (ACS). This multi-biomarker approach enhances risk stratification for high-risk ACS patients.

Keywords:
ALBI scoreBUN/creatinine ratioCARGRACE scoreacute coronary syndrome

More Related Videos

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty
10:03

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty

Published on: January 28, 2020

5.8K
A Research Method For Detecting Transient Myocardial Ischemia In Patients With Suspected Acute Coronary Syndrome Using Continuous ST-segment Analysis
18:11

A Research Method For Detecting Transient Myocardial Ischemia In Patients With Suspected Acute Coronary Syndrome Using Continuous ST-segment Analysis

Published on: December 28, 2012

24.7K

Related Experiment Videos

Last Updated: Jan 13, 2026

Author Spotlight: Integrated Multi-Omics Analysis for Unveiling Multicellular Immune Signatures in Clinical Heart Attack Cohorts
08:51

Author Spotlight: Integrated Multi-Omics Analysis for Unveiling Multicellular Immune Signatures in Clinical Heart Attack Cohorts

Published on: September 20, 2024

2.0K
Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty
10:03

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty

Published on: January 28, 2020

5.8K
A Research Method For Detecting Transient Myocardial Ischemia In Patients With Suspected Acute Coronary Syndrome Using Continuous ST-segment Analysis
18:11

A Research Method For Detecting Transient Myocardial Ischemia In Patients With Suspected Acute Coronary Syndrome Using Continuous ST-segment Analysis

Published on: December 28, 2012

24.7K

Area of Science:

  • Cardiology
  • Biomarker Research
  • Predictive Analytics

Background:

  • The GRACE score is a standard tool for predicting early mortality in acute coronary syndromes (ACS).
  • Existing models may not fully capture the interplay of inflammation, liver, and kidney dysfunction in ACS prognosis.
  • Novel biomarkers are needed to refine risk stratification in ACS patients.

Purpose of the Study:

  • To assess the incremental prognostic value of a multi-biomarker model (CAR, ALBI, BUN/Cr) beyond the GRACE score for in-hospital mortality in ACS.
  • To determine if integrating inflammatory, hepatic, and renal biomarkers improves risk prediction in ACS.

Main Methods:

  • Retrospective analysis of ACS patients' baseline laboratory data.
  • Calculation of C-reactive protein/albumin ratio (CAR), albumin-bilirubin (ALBI) score, and blood urea nitrogen/creatinine (BUN/Cr) ratio.
  • Logistic regression and ROC curve analysis to compare predictive accuracy of GRACE score alone versus the integrated multi-biomarker model.

Main Results:

  • Elevated CAR, ALBI, and BUN/Cr ratios were independently associated with increased in-hospital mortality in ACS patients.
  • The multi-biomarker model significantly improved the predictive accuracy of the GRACE score.
  • The integrated model showed a higher area under the curve (AUC) compared to the GRACE score alone.

Conclusions:

  • A multi-biomarker strategy combining CAR, ALBI, and BUN/Cr ratios offers enhanced early mortality prediction in ACS.
  • These readily available laboratory markers can aid clinicians in precise identification of high-risk ACS patients upon admission.